Abstract
Background: Despite deprescribing initiatives to curb overutilization of proton pump inhibitors (PPIs), achieving meaningful reductions in PPI use is proving a challenge. Summary: An international group of primary care doctors and gastroenterologists examined the literature surrounding PPI use and use-reduction to clarify: (i) what constitutes rational PPI prescribing; (ii) when and in whom PPI use-reduction should be attempted; and (iii) what strategies to use when attempting PPI use-reduction. Key Messages: Before starting a PPI for reflux-like symptoms, patients should be educated on potential causes and alternative approaches including dietary and lifestyle modification, weight loss, and relaxation strategies. When commencing a PPI, patients should understand the reason for treatment, planned duration, and review date. PPI use at hospital discharge should not be continued without a recognized indication for long-term treatment. Long-term PPI therapy should be reviewed at least annually. PPI use-reduction should be based on the lack of a rational indication for long-term PPI use, not concern for PPI-associated adverse events. PPI use-reduction strategies involving switching to on-demand PPI or dose tapering, with rescue therapy for rebound symptoms, are more likely to succeed than abrupt cessation.
Original language | English (US) |
---|---|
Pages (from-to) | 211-220 |
Number of pages | 10 |
Journal | Digestive Diseases |
Volume | 42 |
Issue number | 3 |
DOIs | |
State | Published - Mar 21 2024 |
Funding
This work is based on workshops that were funded by Reckitt Benckiser Healthcare Ltd. Editorial assistance was provided by Lumanity, UK, and funded by Reckitt Benckiser Healthcare Ltd.
Keywords
- Gastroesophageal reflux disease
- Oesophagus
- Proton pump inhibitors
ASJC Scopus subject areas
- Gastroenterology